Bentley
- Company typePrivate
- Founded2009
- HeadquartersHechingen, Germany
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Bentley firmographics
Firmographics- Name
- Bentley
- Legal name
- Bentley Endovascular Group AB
- Website
- https://bentley.global
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Bentley industry classification
Industry- Product category
- Endovascular medical devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts (HLAHAFAF)
- akta.pro secondary industries
- Infusion Sets, Catheters & Pump Consumables (HLAHAIAH), Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)
Keywords
Where Bentley is headquartered
LocationHeadquarters
- HQ city
- Hechingen
- HQ country
- Germany
- HQ region
- Europe
Offices4 records
Markets served
Bentley business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales - Implants and Catheters: Bentley develops, manufactures, and markets implants and catheters for endovascular treatment of peripheral and aortic vascular diseases. Revenue generated from direct and indirect sales across 80+ countries. Products include covered stents (BeGraft, BeGraft Plus, BeFlared, BeFlow, BeSmooth) and catheters (BeBack).
Go-to-market motion3 records
Distribution channels2 records
Marketing channels4 records
Bentley product offering
Product offeringCore offering
Bentley develops, manufactures, and markets balloon-expandable covered stents, uncovered stents, and catheters for the endovascular treatment of peripheral and aortic vascular diseases. Its portfolio includes the BeGraft family of covered stents (coronary, peripheral, aortic, and Plus variants), the BeFlared FEVAR bridging stent, BeFlow iliac stent, BeSmooth peripheral stent, BeYond venous stent, and the BeBack crossing catheter, sold to hospitals and vascular specialists in over 80 countries.
Product overview
Bentley is a global medical technology company offering a unified portfolio of balloon-expandable covered stents, uncovered stents, and catheters for the endovascular treatment of peripheral vascular and aortic diseases. The core portfolio centers on the BeGraft family of covered stents (including BeGraft, BeGraft Plus, and BeGraft peripheral PLUS), the BeFlared FEVAR bridging stent (world's first dedicated bridging stent for fenestrated procedures), the BeFlow iliac covered stent, the BeSmooth peripheral stent, the BeYond venous stent, and the BeBack crossing catheter. These products are complemented by a set of digital and service platforms: the E-Labeling portal for digital implant documentation, the Partner Area for distribution partners, the Webshop for product ordering, and the BeShared case advice service for clinical consultation. The portfolio is designed as a comprehensive endovascular solutions ecosystem, with products developed and manufactured exclusively in Germany and Switzerland.
Differentiator
Problem solved
Functional benefit
Brands
- BeShared: Bentley Case Advice Service for physician case consultation
- Mulliner
Products and services
- BeGraft Covered Stent System Balloon-expandable covered stent system for coronary and peripheral vascular interventions, available in multiple variants (BeGraft coronary, BeGraft peripheral, BeGraft peripheral PLUS, and BeGraft aortic). Engineered for precision placement with high radial force and reliable sealing performance.
- BeGraft Plus Stent Graft System Advanced balloon-expandable covered stent graft system with extended length options up to 78 mm for bridging in complex branched aortic repair (BEVAR). Features a unique stent-in-stent design providing strong fixation and secure sealing, high radial force, exceptional kink resistance, and lateral flexibility.
- BeFlared FEVAR Bridging Stent System World's first dedicated bridging stent specifically developed for FEVAR (Fenestrated Endovascular Aneurysm Repair) procedures. Combines a stepped balloon design with a third radiopaque marker enabling precise and controlled one-step deployment within graft fenestrations. Available in diameters 5–9 mm and stent lengths of 22, 27, and 37 mm.
Quantifiable outcome
- 99% delivery reliability
- +3 more outcomes
Companies that use Bentley
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles1 record
Bentley technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Bentley partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and flagship.
- Cook MedicalcoreClinical collaboration for ZENITH FENESTRATED+ Endovascular Graft (ZFEN+) clinical study using Bentley's BeGraft as the bridging stent. Final patient enrolled October 2025. Study supports Bentley's entry into US market by 2028.
- Terumo AorticflagshipClinical study collaboration for FDA IDE approval combining Terumo Aortic's Fenestrated TREO device with Bentley's BeFlared FEVAR Bridging Stent Graft System. IDE submission planned for first half 2026. Both companies plan to independently market products in US following approval.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Bentley competitors and assessment
Company assessmentDirect peers
- Terumo Aortic: Aortic stent graft specialist and Bentley's named clinical study partner for FDA IDE submission on FEVAR procedures. Sells fenestrated and branched aortic endografts that compete directly with Bentley's BeGraft Plus and BeFlared.
- Cook Medical: Endovascular aortic repair incumbent whose ZENITH FENESTRATED+ graft pairs with Bentley's BeGraft in a clinical collaboration. Direct competitor in AAA and FEVAR bridging stents globally.
- W. L. Gore & Associates (Gore Medical): Manufacturer of the GORE EXCLUDER and other endovascular aortic stent grafts. Direct competitor to Bentley's BeGraft family and BeFlared bridging stent across peripheral and aortic interventions.
- Artivion (formerly CryoLife/Jotec): Owner of the Jotec aortic stent graft franchise following the CryoLife acquisition. Closely comparable European-headquartered endovascular competitor in covered stents and aortic devices.
- Endologix: US-focused manufacturer of abdominal aortic aneurysm (AAA) stent graft systems. Direct competitor to Bentley's aortic disease portfolio in the US market Bentley is preparing to enter.
- MicroPort Scientific (Lombard Medical): Owns the Lombard Medical endovascular aortic franchise (Aorfix). Competes with Bentley in the iliac and abdominal aortic covered stent space.
Broad incumbents
- Medtronic: Broad MedTech incumbent with a leading endovascular portfolio including the Endurant aortic stent graft system. Competes with Bentley in peripheral and aortic covered stents while serving the same vascular surgeons and interventional radiologists.
- Abbott Vascular: Broader vascular franchise overlapping with Bentley in peripheral vascular intervention products and physician relationships. Provides scale and incumbent distribution that Bentley must match in hospital accounts.
- Becton Dickinson (BD Interventional): Through its acquisition of C.R. Bard and BTG, BD operates a sizeable peripheral vascular and endovascular catheter portfolio. Overlaps with Bentley on catheters (e.g., crossing catheters) and certain peripheral solutions.
Emerging players
- Penumbra: Vascular intervention specialist growing in peripheral and venous indications with overlapping physician call points. Emerges as a meaningful adjacent competitor in endovascular access and treatment segments served by Bentley.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Bentley social profiles
Digital presenceBentley compliance and trust
Trust signalCompliance4 records
Bentley financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bentley leadership team
Management profileNumber of profiles
Profiles8 records
Bentley subsidiaries and ownership
Company hierarchySubsidiaries1 record
Bentley funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bentley M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bentley
What does Bentley do?
Bentley develops, manufactures, and markets balloon-expandable covered stents, uncovered stents, and catheters for the endovascular treatment of peripheral and aortic vascular diseases. Its portfolio includes the BeGraft family of covered stents (coronary, peripheral, aortic, and Plus variants), the BeFlared FEVAR bridging stent, BeFlow iliac stent, BeSmooth peripheral stent, BeYond venous stent, and the BeBack crossing catheter, sold to hospitals and vascular specialists in over 80 countries.
Is Bentley a public or private company?
Bentley is a private company. It is classified as venture growth investor backed and is currently operating.
When was Bentley founded?
Bentley was founded in 2009. It employs 251 to 500 people.
Where is Bentley based?
Bentley is headquartered in Hechingen, Germany, in the Europe region.
How does Bentley make money?
One revenue line is on record: medical Device Sales - Implants and Catheters.
Who are Bentley's main competitors?
Direct peers on record are Terumo Aortic, Cook Medical, W. L. Gore & Associates (Gore Medical), Artivion (formerly CryoLife/Jotec), Endologix and MicroPort Scientific (Lombard Medical). Broad incumbents are Medtronic, Abbott Vascular and Becton Dickinson (BD Interventional). Penumbra is listed as an emerging player.
Does Bentley have an API?
No public API is recorded for Bentley.
What industry is Bentley in?
Bentley's product category is Endovascular medical devices. Its primary akta.pro industry code is HLAHAFAF, Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts, with a secondary code of HLAHAIAH, Infusion Sets, Catheters & Pump Consumables. Its NAICS code is 339113 and its SIC code is 3841.